CombinatoRx
Cambridge · Founded 2000
About CombinatoRx
CombinatoRx is a biotech company that develops medicines from synergistic combinations of approved drugs. The company has pushed into Phase 2 clinical trials a portfolio of drug candidates aimed at cancer and multiple immuno-inflammatory diseases. CombinatoRx Service Business was acquired by Horizon Discovery Group.
Company Facts
- Founded: 2000
- Legal name: CombinatoRx, Incorporated
- Operating status: Acquired
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $70.0M
- Funding stage: M&A
- Last round: Series C (Mar 2004)
- Website: combinatorx.com
Canonical: https://fsome.com/organization/combinatorx-8356718 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.